As key signaling molecules involved in tumor immune escape, immune suppression, tumor cell migration, and angiogenesis, the enhanced MIF and CD99 signaling pathways in RCC indicate that the interaction between immune cells and MCs in the TME may significantly promote immune escape and angiogenesis, potentially contributing to poor prognosis in RCC patients. Here, CD99 is linked to neoplasm.